Gut environmental factors and multiple sclerosis

Journal of Neuroimmunology

Volumn 329, Issue , 2019, Pages 20-23

  Miyake, Sachiko ^a   Yamamura, Takashi ^b  

^a Department of Immunology ^*  (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; POLYAMINE DERIVATIVE; SHORT CHAIN FATTY ACID;

COMMENSALISM; DYSBIOSIS; ENVIRONMENTAL FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HOST MICROBE INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; INTESTINE FLORA; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; IMMUNOLOGY;

ANIMALS; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; MULTIPLE SCLEROSIS;

EID: 85050826494     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2018.07.015     Document Type: Review

References (72)

1. + natural killer T cells derived from multiple sclerosis in remission. Int. Immunol. 15 (2003), 279–288.
2. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., Deroos, P., Liu, H., Cross, J.R., Pfeffer, K., Coffer, P.J., Rudensky, A.Y., Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504 (2013), 451–455.
3. Ascherio, A., Munger, K.L., Lunemann, J.D., The initiation and prevention of multiple sclerosis. Nat. Rev. Neurol. 8 (2012), 602–612.
4. Atarashi, K., Tanoue, T., Oshima, K., Imaoka, A., Kuwahara, T., Momose, Y., Chen, G., Yamasaki, S., Saito, T., Ohba, Y., Taniguchi, T., Takeda, K., Hori, S., Ivanov, I.I., Umesaki, Y., Itoh, K., Honda, K., Induction of colonic regulatory t cells by indigenous clostridium species. Science 331 (2011), 337–341.
5. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., Kim, S., Fritz, J.V., Wilmes, P., Ueha, S., Matsushima, K., Ohno, H., Olle, B., Sakaguchi, S., Taniguchi, T., Morita, H., Hatori, M., Honda, K., Nature 500 (2013), 232–236.
6. Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W., Imaoka, A., Setoyama, H., Nagamori, T., Ishikawa, E., Shima, T., Hara, T., Kado, S., Jinnohara, T., Ohno, H., Kondo, T., Toyooka, K., Watanabe, E., Yokoyama, S., Tokoro, S., Mori, H., Noguchi, Y., Morita, H., Ivanov, I.I., Sugiyama, T., Nunez, G., Camp, J.G., Hatori, M., Umesaki, Y., Honda, K., Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163:2 (2015), 367–380.
7. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., Wekerle, H., Krishnamoorthy, G., Nature 479 (2011), 538–541.
8. Cantarel, B.L., Waubant, E., Chehoud, C., Kuczynski, J., Desantis, T.Z., Warrington, J., Venkatesan, A., Fraser, C.M., Mowry, E.M., Gut microbiota in MS. J. Investig. Med. 63:2 (2015), 729–734.
9. Chang, M.C., Tsai, Y.L., Chen, Y.W., Chan, C.P., Huang, C.F., Lan, W.C., Lin, C.C., Lan, W.H., Jeng, J.H., Butyrate induces reactive oxygen species production and affects cell cycle progression in human gingival fibroblasts. J. Peridontal. Res. 48:1 (2012), 66–73.
10. Chang, P.V., Hao, L., Offermanns, S., Medzhitov, R., The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. U. S. A. 111:6 (2014), 2247–2252.
11. Chen, J., Chia, N., Kalari, K.R., Yao, J.Z., Novotna, M., Mateo Paz Solda, M., Lucky, D.H., Marietta, E.V., Jeraldo, P.R., Chen, X., Weinshenker, B.G., Rodriguez, M., Kanatarci, H.O., Nelson, H., Murray, J.A., Mangalam, A.K., Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci. Rep., 6, 2016, 28484.
12. Cherrier, M., Eberl, G., The development of LTi ells. Curr. Opin. Immunol. 24 (2012), 178–183.
13. Chiba, A., Kaieda, S., Oki, S., Yamamura, T., Miyake, S., The involvement of Vα14 NKT cells in the pathogenesis of murine models of arthritis. Arthritis Rheum. 52 (2005), 1941–1948.
14. Chiba, A., Tajima, R., Tomi, C., Miyazaki, Y., Yamamura, T., Miyake, S., Mucosal-associated invariant T cells promote inflammation and exacerbate disease in murine models of arthritis. Arthritis Rhem., 64(153–61), 2012, 2012.
15. Chiba, A., Tamura, N., Yoshikiyo, K., Murayama, G., Kitagaichi, M., Yamaji, K., Takasaki, Y., Miyake, S., Activation status of mucosal-assoiciated invariant T cells reflects disease activety and pathology of systemic lupus erythematousus. Arthritis. Res. Ther., 19(1), 2017, 58.
16. Cosnes, J., Gower-Rousseau, C., Seksik, P., Cortot, A., Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140 (2011), 1785–1794.
17. Croxford, J.L., Miyake, S., Immunoregulation of multiple sclerosis by gut environmental factors. Clin. Exp. Neuroimmunol. 6:4 (2015), 362–369.
18. Croxford, J.L., Miyake, S., Huang, Y.-Y., Shimamura, M., Yamamura, T., Invariant Vα19i T cells regulate autoimmune inflammation. Nat. Immunol. 7 (2006), 987–994.
19. De Goffau, M.C., Fuentes, S., van den Bogert, B., Honkanen, H., de Vos, W.M., Welling, G.W., Hyoty, H., Hamsen, H.J., Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 57:8 (2014), 1569–1577.
20. Eder, W., Ege, M.J., von Mutius, E., The asthma epidemic. N. Engl. J. Med. 355 (2006), 2226–2235.
21. Erny, D., Hrabě De Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermöhlen, O., Chun, E., Garrett, W.S., McCoy, K.D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I., Prinz, M., Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18 (2015), 965–977.
22. Esplugues, E., Huber, S., Gagliani, N., Hauser, A.E., Town, T., Wan, Y.Y., O'Connor, W. Jr., Rongvaux, A., Van Rooijen, N., Haberman, A.M., Iwakura, Y., Kuchroo, V.K., Kolls, J.K., Bluestone, J.A., Herold, K.C., Flavell, R.A., Control of TH17 cells occurs in the small intestine. Nature 475 (2011), 514–518.
23. Fung, T.C., Olson, C.A., Hsiao, E.Y., Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 20 (2017), 145–155.
24. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N.N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., Clarke, J.M., Topping, D.L., Tomita, M., Hori, S., Ohara, O., Morita, T., Koseki, H., Kikuchi, J., Honda, K., Hase, K., Ohno, H., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
25. Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., Eberl, G., Snel, J., Kelly, D., Cerf-Bensussan, N., The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:4 (2009), 677–689.
26. Ghorbani, P., Santhakumar, P., Hu, Q., Dijadeu, P., Wolever, T.M., Palaniyar, N., Grasemann, H., Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth. Eur. Respir. J. 46:4 (2015), 1033–1045.
27. Haga, K., Chiba, A., Shibuya, T., Osada, T., Ishikawa, D., Kodani, T., Nomura, O., Watanabe, S., Miyake, S., MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis. J. Gastroenterol. Hepatol. 31:5 (2016), 965–972.
28. Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.H., May, C., Wilck, N., Balogh, A., Ostermann, A.I., Schebb, N.H., Akkad, D.A., Grohme, D.A., Kleinewietfeld, M., Kempa, S., Thöne, J., Demir, S., Müller, D.N., Gold, R., Linker, R.A., Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43:4 (2015), 817–829.
29. Hayashi, E., Chiba, A., Tada, K., Haga, K., Kitagaich, M., Nakajima, S., Kusaoi, M., Sekiya, F., Ogasawara, M., Yamaji, K., Tamura, N., Takasaki, Y., Miyake, S., Involvement of mucosal-associated invariant T cells in ankylosing spondylitis. J. Rheumatol. 43:9 (2016), 1695–1703.
30. Hill, D.A., Artis, D., Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 28 (2010), 623–667.
31. International Multiple Sclerosis Genetics Consortium;Wellcome Trust Case Control Consortium 2, Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476 (2011), 214–219.
32. Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., Tanoue, T., Imaoka, A., Itoh, K., Takeda, K., Umesaki, Y., Honda, K., Littman, D.R., Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:3 (2009), 485–498.
33. Izcue, A., Coombes, J.L., Powrie, F., Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27 (2009), 33–338.
34. Jangi, S., Gandhi, R., Cox, L.M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M.A., Liu, S., Glanz, B.L., Coo, S., Tankou, S., Stuart, F., Milo, K., Nejad, P., Smith, K., Topcuolu, B.D., Hode, J., Kivisakk, P., Chitnis, T., De Jager, P.L., Quintana, F.J., Gerber, G.K., Try, L., Weiner, H.L., Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun., 7, 2016, 12015.
35. Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., Vermeire, S., Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60 (2011), 631–637.
36. Kadowaki, A., Miyake, S., Saga, R., Chiba, A., Mochizuki, H., Yamamura, T., Gut environment-induced intraepithelial autoreactive CD4+ T cells suppress central nervous system autoimmunity via LAG-3. Nat. Commun., 7, 2016 (Article number 11639).
37. Kendrick, S.F., O'Boyle, G., Mann, J., Zeybel, M., Palmer, J., Jones, D.E., Day, C.P., Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology 51:6 (2010), 1988–1997.
38. Kostic, A.D., Gevers, D., Siljander, H., Vatanen, T., Hyotylaninen, T., Hamalaninen, A.M., Peet, A., Tillmann, V., Poho, P., Mattila, I., Lahdesmaki, H., Franzaosa, E.A., Vaarala, O., de Goffau, M., Harmasen, H., Ilonen, J., Virtanen, S.M., Clish, C.B., Oresic, M., Huttenhower, C., Knip, M., DIABIMMUNE Study Group, Xavier, R.J., The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17:2 (2015), 260–273.
39. Lee, Y.K., Menezes, J.S., Umesaki, Y., Mazmanian, S.K., Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 4615–4622.
40. Levy, M., Kolodziejczyk, A.A., Thaiss, C.A., Elinav, E., Dysbiosis and the immune system. Nat. Rev. Immuol. 17 (2017), 219–232.
41. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Martequ, P., Roca, J., Dore, J., Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomics approach. Gut 55:2 (2006), 205–211.
42. Maynard, C.L., Elson, C.O., Hatton, R.D., Weaver, C.T., Reciprocal interactions of the intestinal microbiota and immune system. Nature 489 (2012), 231–241.
43. Miyake, S., Yamamura, T., Therapeutic potential of CD1d-restriced invariant natural killer T cell-based treatment for autoimmune diseases. Int. Rev. Immunol. 26 (2007), 73–94.
44. Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., Morita, H., Hattori, M., Yamamura, T., Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS ONE, 10(9), 2015, e0137429.
45. Miyazaki, Y., Miyake, S., Chiba, A., Lantz, O., Yamamura, T., Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int. Immunol. 23 (2011), 529–535.
46. Mizuno, M., Noto, D., Kaga, N., Chiba, A., Miyake, S., The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS ONE, 12(2), 2017, e0173032.
47. Mondot, S., Kang, S., Furet, J.P., Aguirre de Carcer, K., McSweeney, C., Morrison, M., Marteau, P., Dore, J., Lecierc, M., Highlighting new phylogenetic specificities of Crohn's desease microbiota. Inflamm. Bowel Dis. 17 (2011), 185–192.
48. Mosca, A., Lecierc, M., Hugot, J.P., Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem?. Front. Microbiol., 7, 2016, 455.
49. Ochoa-Repáraz, J., Mielcarz, D.W., Ditrio, L.E., Burroughs, A.R., Foureau, D.M., Haque-Begum, S., Kasper, L.H., Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 183:10 (2009), 6041–6050.
50. Ochoa-Repáraz, J., Mielcarz, D.W., Wang, Y., Begum-Haque, S., Dasgupta, S., Kasper, D.L., Kasper, L.H., A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 3:5 (2010), 487–495.
51. Ochoa-Repáraz, J., Mielcarz, D.W., Ditrio, L.E., Burroughs, A.R., Begum-Haque, S., Dasgupta, S., Kasper, D.L., Kasper, L.H., Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide a expression. J. Immunol. 185:7 (2010), 4101–4108.
52. Olsson, T., Barcellos, L.F., Alfredsson, L., Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat. Rev. Neurol. 13 (2017), 25–36 36.
53. Otto, S.J., Musfeldt, M., Wenderoth, D.F., Hampe, J., Brant, O., Folsch, U.R., Timmis, K.N., Schireiber, S., Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel diseases. Gut 53:5 (2004), 685–693.
54. Patterson, C.C., Dahlquist, G.G., Gyürüs, E., Green, A., Soltész, G., Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373 (2009), 2027–2033.
55. Patterson, C.C., Dahlquist, G.G., Gyurus, E., Green, A., Soltesz, G., Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new casese 2005-20: a multicenter prospective registration study. Lancet 373 (2009), 2027–2033.
56. Rook, G.A., Hygiene hypothesis and autoimmune diseases. Clin. Rev. Allergy Immunol. 42 (2012), 5–15.
57. Rooks, M.G., Garrett, W.S., Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16 (2016), 341–352.
58. Singh, N., Thangaraju, M., Prasad, P.D., Martin, P.M., Lambert, N.A., Boettger, T., Offermanns, S., Ganapathy, V., Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J. Biol. Chem. 285:36 (2010), 27601–27608.
59. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Glickman, J.N., Garrett, W.S., The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:6145 (2013), 569–73.20.
60. Smythies, L.E., Sellers, M., Clements, R.H., Mosteller-Barnum, M., Meng, G., Benjamin, W.H., Orenstein, J.M., Smith, P.D., Human intestinal macrophages display profound inflammatory anergy depite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115 (2005), 66–75.
61. Sokol, H., Pigneur, B., Watterot, L., Lakhadri, O., Bermudez-Humaran, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., Grangette, C., Vasquez, N., Pochart, P., Trugnan, G., Thomas, G., Blottiere, M., Dore, J., Marteau, P., Seksik, P., Langella, P., Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 195 (2008), 16731–16736.
62. Strachan, D.P., Hay fever, hygine and household size. BMJ 299 (1989), 1259–1260.
63. Tao, R., de Zoeten, E.F., Ozkaynak, E., Chen, C., Wang, L., Porrett, P.M., Li, B., Turka, L.A., Olson, E.N., Greene, M.I., Wells, A.D., Hancock, W.W., Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13:11 (2007), 1299–1307.
64. Thorburn, A.N., Macia, L., MacKay, C.R., Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity 40:6 (2014), 833–842.
65. Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L.P., Harris, N.L., Marsland, B.J., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20:2 (2014), 159–166.
66. Tsuji, M., Suzuki, K., Kitamura, H., Maruya, M., Kinoshita, K., Ivanov, I.I., Itoh, K., Littman, D., Fagarasan, S., Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin a generation in the gut. Immunity 29:2 (2008), 261–271.
67. Usami, M., Kishimoto, K., Ohata, A., Miyoshi, M., Aoyama, M., Fueda, Y., Kotani, J., Butyrate and trichostatin a attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr. Res. 28:5 (2008), 321–328.
68. Vinolo, M.A., Rodrigues, H.G., Hatanaka, E., Sato, F.T., Sampaio, S.C., Curi, R., Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22:9 (2011), 849–855.
69. Wang, Y., Telesford, K.M., Ochoa-Repáraz, J., Haque-Begum, S., Christy, M., Kasper, E.J., Wang, L., Wu, Y., Robson, S.C., Kasper, D.L., Kasper, L.H., An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat. Commun., 5, 2014, 4432.
70. Wingerchuk, D.M., Carter, J.L., Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin. Proc. 89 (2014), 225–240.
71. World Health Organization, Atlas: Multiple Sclerosis Resources in the World. 2008, WHO, Geneva.
72. Yokote, H., Miyake, S., Croxford, J.L., Oki, S., Mizusawa, H., Yamamura, T., NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Ame. J. Patho. 173 (2008), 1714–1723.